Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Mycophenolate mofetil manufacturers?

See the DrugPatentWatch profile for Mycophenolate

Mycophenolate mofetil (MMF) is a widely used immunosuppressant, especially in organ transplantation and certain autoimmune diseases. Because it’s a generic‑eligible compound, a number of pharmaceutical companies produce it in various formulations and strengths. Below is a snapshot of the major manufacturers (as of 2024) that are commonly found in the U.S. and other large markets:

Brand / Generic Manufacturer Notes
Cellcept Pfizer (now part of Pfizer’s generic arm) Original brand name; still widely used in transplant protocols.
Myfortic Mylan (now part of Viatris) One of the most common generic MMF tablets (125 mg and 250 mg).
Myfortic® (Generic) Teva Teva’s generic line, often offered at lower cost.
Myfortic® (Generic) Sandoz Another major generic supplier.
Myfortic® (Generic) Cipla Available in India and export markets.
Myfortic® (Generic) Mylan Various strengths, including 500 mg tablets.
Myfortic® (Generic) Glenmark Indian generic, often used in developing‑country markets.
Myfortic® (Generic) Sun Pharmaceutical Industries Part of Sun Pharma’s immunosuppressant portfolio.
Myfortic® (Generic) Dr. Reddy's Also an Indian manufacturer with a broad global reach.
Myfortic® (Generic) Boehringer Ingelheim (in partnership with other companies) In some regions, this group offers MMF.
Myfortic® (Generic) Pfizer (generic division) Pfizer’s own generic line in some markets.
Other Generic Variants Many others In Europe, Asia, and Latin America, numerous local manufacturers produce MMF under various trade names.

How the Market Works

  1. Brand‑name vs. Generic – The original brand, Cellcept, is typically priced higher. Once patent protection expires, generic versions appear; these are usually cheaper but must meet the same quality standards (e.g., FDA or EMA approval).
  2. Approval & Quality – In the U.S., generics must be approved by the FDA under the 505(b)(2) pathway and must demonstrate bioequivalence to the brand. In the EU, the European Medicines Agency (EMA) provides a similar evaluation.
  3. Availability – The availability of a specific manufacturer’s product can vary by region, pharmacy chain, and insurance coverage. For instance, Viatris’ Myfortic is common in the U.S., while Teva’s version may dominate in Canada or other Commonwealth countries.

Tips for Patients & Healthcare Providers

  • Consult Your Provider: They’ll decide the most appropriate formulation and dose based on your medical condition, renal function, and potential drug interactions.
  • Insurance & Cost: Ask your pharmacy about the most cost‑effective generic available. Pharmacies often have discount programs for brand names as well.
  • Watch for Bioequivalence: If switching between generics, it’s generally safe, but if you notice any change in efficacy or side‑effects, inform your prescriber immediately.
  • Supply Chain Updates: Pharmaceutical manufacturing can experience shortages; always keep your prescriber updated if you experience a shortage or discontinuation.

Quick Takeaway

  • PfizerCellcept (brand)
  • Viatris (Mylan)Myfortic (generic)
  • Teva, Sandoz, Cipla, Glenmark, Sun Pharma, Dr. Reddy’s, etc. → Various generic versions

If you’re looking for a specific formulation (e.g., 250 mg tablets vs. 500 mg), or you have questions about pricing, dosage adjustments, or drug interactions, let me know—I’m happy to dive deeper!



Other Questions About Mycophenolate :

Cost of mycophenolate? Mycophenolate sodium coupon? How much does mycophenolate cost? How much is mycophenolate? Mycophenolate mofetil oral suspension price? Mycophenolate cost without insurance? Mycophenolate 250 mg?